Dow Corning may pool unresolved breast implant cases under Chapter 11 filing.
This article was originally published in The Gray Sheet
Executive SummaryDOW CORNING MAY SEEK TO CONSOLIDATE "OPT-OUT" LIABILITY CLAIMS from silicone breast implant recipients as part of a Chapter 11 bankruptcy filing, the company says. Dow Corning reports that if it files for bankruptcy under Chapter 11, all pending claims against the firm filed by women who are not in the $4.25 bil. "global" class action settlement could be consolidated into a separate class action to be resolved by the bankruptcy court, thereby reducing the company's potential liability from the claims. However, Dow Corning would still maintain its $2 bil. commitment to the global settlement.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.